The Cannabidiol (CBD) industry is so hot right now that everybody from Martha Stewart to Montel Williams is trying to get in on a piece of the action. Now the creator of the original Jelly Belly jelly bean can be added to the list of CBD industry hopefuls.
Candy maker David Klein, the self proclaimed Candyman, created the Rolls-Royce of jelly beans in 1976, and now that CBD is no longer restricted in the United States under the Controlled Substances Act, he had the idea to combine the two to make a come back.
Klein sold his rights to the Jelly Belly name in 1980 in exchange for less than $2.5 million, which he received in the form of $10,000 per month for 20 years. This means that he is not able to label his new CBD-infused-beans with the Jelly Belly name. Instead, Klein’s new jelly beans are branded under the name Spectrum Confections.
“Everything I’ve done in my life was to get me to this point, and I truly believe I’m supposed to help people with my CBD jelly beans,” said Klein.
According to the Spectrum Confections website, they are currently sold out of pre-made product, but wholesale orders will still be accepted. Wholesale orders can be white labeled for self-branded packaging.
CBD Not Included
Spectrum Confections only manufacturers wholesale orders at this time, and unlike many other CBD candy distributors, they do not supply the CBD. Anyone interested in ordering the CBD infused jelly beans must first ship CBD oil or isolate to Spectrum Confections along with certified lab-test results displaying exactly how much CBD and THC is in the product.
Klein then uses the CBD that has been provided by the purchaser to infused his jelly beans. CBD isolate is preferred over the oil, according to Klein, and CBD containing more than 0.30 percent THC will be returned to the purchaser. They will only manufacture products that are legal in the United States, and anything containing more than 0.3 percent THC remains illegal under the Controlled Substances Act.
Original, Sugar Free, and Sour
There are three different types of Spectrum Confections Jelly Beans available in 38 different flavors according to the website: Original Jelly Beans, Sugar Free Jelly Beans, and Sour Jelly beans. One of the sour flavors is called “Sour Cherry Goosebumps.”
In order to “mask the CBD flavor,” the original and sour varieties are mixed with dextrose and malitol is used for the sugar free ones. According to Klein, CBD doesn’t taste great, so it is important to mask the taste of it.
10 Milligrams Each
The recipe used to make Spectrum Confections CBD Jelly Beans produces 10 mg of CBD in each bean. Purchasers are instructed to eat one if they want to consume 10 mg of CBD, eat two if they want to ingest 20 mg, and so on. Compared to many other products, that is delivering a solid dose of CBD in a tiny package. Many other candies containing 10 mg of CBD are eight times the size or more of a jelly bean.
Two pounds of Jelly Belly Jelly Beans go for about $10.50 on Amazon, but the price of the Spectrum Confections Jelly Beans remain a mystery until you contact the company to place an order.
The Come Back…Again
This is not the first come back that the Candyman has attempted in recent years. Klein turned to Kickstarter in 2016 to crowd source funding for his new Coffee House Original Jelly Beans which were infused with caffeine and came in flavors like Chai Tea. He successfully raised $13,650 from 232 contributors.
Klein is also currently working on a creation he calls Polar Corn, a popcorn treat that you “freeze and eat.”
Photo Courtesy of Spectrum Confections
While smoking a joint and streaming live on Instagram Thursday night, David Irving, defensive lineman for the Dallas Cowboys, announced that he is quitting his job with the National Football League (NFL).
“Basically, guys, I quit. I know they’re talking about a suspension and all this other nonsense. I’m out of there. I’m not doing this sh** no more,” Irving said during the video stream on Instagram Live.
Irving completed the live stream in response to being suspended indefinitely by the Cowboys after his urine tested positive for the tetrahydrocannabinol (THC) metabolite again. This is the third time he has been suspended in four years for failing to abide by the league’s outdated drug policy.
“Everyone questions my commitment to football,” he said. “But let’s it straight…I love football…However, I don’t love the NFL. The NFL isn’t football.”
Like many others, Irving has expressed many times that he believes NFL players should be permitted to medicate and treat injuries with cannabis instead of opioids if they choose. He supports the #plantsoverpills movement with the hashtag proudly displayed at the top of his Instagram page. He also repeated the statement multiple times during the nearly 20 minute Instagram Live video stream.
One thing was made clear during the stream: Irving thinks it’s bullsh**.
“We got this opioid thing going on and I’m prescribed all that bullsh**, and I just think it’s bullsh** that we’ve got to deal with that policy,” he said during the Instagram Live stream. “Everyone thinks it’s about smoking weed. It’s not about smoking weed. It’s much bigger than that. Much, much bigger. Hell, I have concussions every day. I get to see around the office how that f—s your head up and I feel it.”
“How many NBA players you see getting in trouble about this? How many coaches you see get in trouble about this? How many baseball players get in trouble? How many UFC players getting in trouble? How many actors? Not many, but you do see us football players,” Irving said.
While some are saying that Irving is quitting the NFL solely because of it’s cannabis policy, he insists that is not the only reason.
“If I’m going to be addicted to something, I’d rather it be marijuana, which is medical,” Irving continued. “I do not consider it a drug, rather than the Xanax bars or the hydro[codone] or the Seroquel and all that crazy sh** that they feed you. Like I said, it ain’t about smoking weed.”
While his point is valid and worth noting, some criticize the way Irving went about delivering the message. It is possible that it could have been more well received by a larger audience if he had expressed his views in a different manner.
Irving has joined the ranks of so many other NFL players, both active and retired, who have spoken out in support of using cannabis to treat symptoms caused by injuries sustained during games, like concussions, muscle tears, and broken bones.
NFL players can only be drug tested from April through August. If a player does not fail his drug test the first time, it will be another year before he can be tested again. This is how some players are able to medicate with cannabis during the season, assuming they are able to pass the drug test the first time.
At only 25 years old, Irving was a promising player in the NFL when he was able to stay on the field. He made four tackles and one sack in the only two games he played for the Cowboys during the most recent season. The season before that, Irving sacked the quarterback seven times in eight games. He was about to become a free agent, but apparently he no longer has any interest in exploring his options with the NFL.
What will Irving do next if he isn’t going to play football? He says he has big plans for the future, and that they will be revealed soon enough. Perhaps Irving will follow in the footsteps of other ex-professional-athletes like Tiki Barber and Ricky Williams by launching his own cannabis brand or investing in an existing cannabis business.
Cannabidiol (CBD), the non-psychoactive cannabinoid praised for medicinal powers like reducing the severity and frequency of seizures in children suffering from rare and otherwise untreatable forms of epilepsy, may not be the most medically beneficial molecule found in cannabis, according to new data.
The U.S. government and people who are uncomfortable with the high that is produced by the main psychoactive cannabinoid occurring in cannabis, tetrahydrocannabinol (THC), have accepted CBD with open arms in recent years by adding it to coffee, skincare regimens, and personal lubricant. Meanwhile, THC remains federally illegal under the Controlled Substance Act.
A new study published in the journal Scientific Reports on February 25, 2019, compared data submitted to the Releaf App between June 6, 2016, and March 5, 2018. During that time, 3,341 users of the app reported results from 19,910 different cannabis-use experiences.
This data study is the first to measure how different characteristics of cannabis produce different effects in users.
During the reporting process from the app, users record details like what type of product they are using, what the reported cannabinoid content is, and which method of delivery is being utilized per experience.
The different types of cannabis products reported include:
- Dried flower
The different methods of delivery include:
- Smoking or combusting
- Applying topically
The Releaf App was designed with new medical patients and cannabis users in mind, aiming to help them understand what works best to treat their specific symptoms or condition by tracking how different strains and methods of delivery affect them. The app also records the lab-reported level of each cannabinoid, like THC and CBD, that is in each product. Adverse side effects, like dry mouth and paranoia, are also reported by users.
Users record how they feel before consumption and then again immediately following administration to understand which method provides the most relief.
CBD VS. THC
While the levels of CBD in a product did not correlate with the symptom relief that was reported, the products with higher levels of THC were strongly linked to symptom relief, according to the Releaf App data.
Dried flower was the most commonly used product during the period of time studied. Dried flower with higher levels of THC was the only product reported to provide the greatest overall symptom relief.
Unlike the relief related to levels of THC, higher CBD content did not correlate with symptom relief, according to the data.
While cannabinoids can still be medicinally beneficial when only one is administered at a time, those aware of the entourage effect understand that cannabinoids work most effectively in conjunction with one another.
This data is a prime example of why cannabis should be removed from the Controlled Substances Act so that scientists can finally have access to the plant for research and studies.
Studies show that men who consume marijuana are more likely to produce semen with a lower concentration of sperm, known as low sperm count, than those who abstain. According to new research from Duke University School of Medicine in North Carolina, smoking cannabis may have an even bigger impact on sperm than previously thought.
The study aimed to learn more about the reproductive effects of a father’s exposure to tetrahydrocannabinol (THC), the most abundant psychoactive cannabinoid in marijuana, and subsequently how it affects embryo development and the lifetime health of the offspring. Samples from both lab rats and humans were used and compared in the research, and the results from both were similar. The sperm from subjects with higher levels of THC in their urine had more pronounced genetic changes.
Following the study, Duke Health announced that “exposure to cannabis alters the genetic profile of sperm,” but “whether genetic changes can be reversed or are passed on to children is still unknown.” The research paper, “Cannabinoid exposure and altered DNA methylation in rat and human sperm,” was published in the journal Epigenetics on December 19, 2018.
Epigenetics explores the biological mechanisms in DNA that turn genes on and off. THC doesn’t mutate the sperm itself, but it may change the way the genes that are passed on to children are regulated and expressed. Researchers believe this information is significant for men of childbearing age because if a child is conceived from a sperm that was altered by exposure to THC, it may impact the development of the child. It is not yet known whether a THC-altered sperm is even capable of fertilizing an egg.
The research team at Duke Health plans to increase the sample size for future studies to learn more about how THC changes the genetic profile of sperm. “In the absence of a larger, definitive study, the best advice would be to assume these changes are going to be there,” said lead author Susan K. Murphy, Ph.D. “We don’t know whether they are going to be permanent. I would say, as a precaution, stop using cannabis for at least six months before trying to conceive.”